Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma

Background: Hepatocellular carcinoma (HCC) accounts for more than 75% of primary liver cancers, which are the second leading cause of cancer-related deaths. The GALAD (gender, age, AFP-L3, AFP, and des-carboxy-prothrombin) score is a diagnostic tool developed based on gender, age, alpha-fetoprotein,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cagnin, Silvia, Donghia, Rossella, Martini, Andrea, Pesole, Pasqua Letizia, Coletta, Sergio, Shahini, Endrit, Boninsegna, Giulia, Biasiolo, Alessandra, Pontisso, Patrizia, Giannelli, Gianluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671761/
https://www.ncbi.nlm.nih.gov/pubmed/38003675
http://dx.doi.org/10.3390/ijms242216485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671761/
https://www.ncbi.nlm.nih.gov/pubmed/38003675
http://dx.doi.org/10.3390/ijms242216485

Ejemplares similares